Kelly Doyle, MS, is a seasoned clinical research and operations professional currently serving as the Director of Licensing and Translations for Clinical Outcomes Assessments and Copyrights at Merck. With extensive experience in clinical operations, Kelly has effectively led strategic initiatives that enhance patient-centered drug development, overseeing governance, licensing, and translation processes. Kelly's background includes roles at various organizations such as Research Pharmaceutical Services, ExecuPharm, and Worldwide Clinical Trials, where they honed skills in cross-functional collaboration and regulatory compliance. Kelly holds a Master of Science in Clinical Research Organization and Management from Drexel University College of Medicine and is pursuing a Doctorate in Business Administration at Marymount University.
This person is not in any teams
This person is not in any offices